Latest Breaking News On - Axsome therapeutics company profile - Page 1 : vimarsana.com

Insider Selling: Axsome Therapeutics, Inc (NASDAQ:AXSM) Director Sells 5,249 Shares of Stock

Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) Director Mark Coleman sold 5,249 shares of the firm’s stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $75.21, for a total value of $394,777.29. Following the completion of the transaction, the director now directly owns 19,848 shares in […]

United statesMark colemanAxsome therapeutics incRafferty asset managementAxsome therapeutics company profilePrincipal financial group incMorgan stanleySecurities exchange commissionWealth groupRoyal bankAxsome therapeuticsGet free reportDirector mark colemanExchange commissionFinancial groupAsset management

Axsome Therapeutics, Inc (NASDAQ:AXSM) Stake Boosted by Meridian Wealth Management LLC

Meridian Wealth Management LLC raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 20,498 shares of the company’s stock after purchasing an additional 1,275 shares during […]

United statesRoger jeffsMarkl jacobsonRobertw bairdMeridian wealth managementExchange commissionWashington trust advisors incCantor fitzgeraldFifth third bancorpAxsome therapeutics company profileMorgan stanleyAxsome therapeutics incThird bancorpSg americas securitiesRoyal bankAxsome therapeutics

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112 00

Axsome Therapeutics (NASDAQ:AXSM) Price Target Raised to $112 00
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdRoger jeffsMarkl jacobsonSecurities exchange commissionAxsome therapeutics company profileRussell investments group ltdCantor fitzgeraldMorgan stanleyAxsome therapeutics incWashington trust advisors incThird bancorpFifth third bancorpChina universal asset management coJaniczek wealth managementAxsome therapeutics

Axsome Therapeutics, Inc (NASDAQ:AXSM) to Post Q3 2025 Earnings of $0 47 Per Share, HC Wainwright Forecasts

Axsome Therapeutics, Inc (NASDAQ:AXSM) to Post Q3 2025 Earnings of $0 47 Per Share, HC Wainwright Forecasts
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United statesRobertw bairdMarkl jacobsonPiper sandlerRoger jeffsRoyal bankCantor fitzgeraldAxsome therapeutics incSei investments coSg americas securitiesAxsome therapeutics company profileMutual of america capital managementRussell investments group ltdProshare advisorsSecurities exchange commissionAxsome therapeutics

Axsome Therapeutics (AXSM) to Release Quarterly Earnings on Monday

Axsome Therapeutics (AXSM) to Release Quarterly Earnings on Monday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesMarkl jacobsonRobertw bairdRoger jeffsAxsome therapeutics incCantor fitzgeraldMorgan stanleyAxsome therapeutics company profileSecurities exchange commissionAxsome therapeuticsGet free reportDirector roger jeffsExchange commissionAxsome therapeutics daily